AstraZeneca PLC is 170.4x more valuable than RAPT Therapeutics, Inc. by market capitalization ($286.27 B vs $1.68 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RAPT | AZN |
|---|---|---|
| Market cap | $1.68 B | $286.27 B |
| US-listed rank | #2241 | #47 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$129.87M | - |
| SEC filings | 569 | 1,004 |
AstraZeneca PLC is 170.4x more valuable than RAPT Therapeutics, Inc. by market capitalization ($286.27 B vs $1.68 B).
Full pages: RAPT Therapeutics, Inc. and AstraZeneca PLC, or browse the full rankings.